AKIP1 and central nervous system cancer: Notably, the inhibitory impacts of AKIP1 insufficiency on the proliferation, migration, invasion, and EMT process of T98G cells were reversed by silencing of DLG2, which indicated that AKIP1 modulated these cell functions so as to affect glioma development by targeting DLG2.